Budget Battles
-
Republicans Want Strings Attached to California Disaster Aid
-
Biden Goes Out With a Bang in the Jobs Market
-
Trump Privately Pushes Senators for ‘One Big, Beautiful Bill’
-
Trump Considers Declaring National Emergency for Tariff Rollout
-
Trump Unloads: Grievances, Greenland and the Gulf of Mexico
-
Republicans Divided Over How to Pass Trump’s Agenda
-
Trump Pushes Johnson to Victory as Speaker
-
Factbox: What happens in a U.S. government shutdown?
By Richard Cowan and Susan Cornwell and Amanda Becker and Richard Cowan and Susan Cornwell and Amanda Becker, ReutersIn shutdowns, nonessential government employees are furloughed, or placed on temporary unpaid leave. Workers deemed essential, including those dealing with public safety and national security, keep...
-
Delaware Sues Opioid Manufacturers, Distributors Over Epidemic
By Nate Raymond, Reuters(Reuters) - Delaware on Friday became the latest state to file a lawsuit accusing corporations of helping fuel the national opioid epidemic, suing a wide range of companies involved in making,...
-
Trump's drug czar nominee withdraws from consideration
By Sarah N. Lynch and Makini Brice, ReutersWASHINGTON (Reuters) - The U.S. lawmaker who was President Donald Trump's pick for drug czar withdrew on Tuesday after a report he spearheaded a bill that hurt the government's ability to crack down...
-
6 Tips for Renovating Your Home Without Getting Ripped Off
Follow these steps to make sure that you’re not spending more than you need to on your home improvement projects.
-
The Risk That’s Growing Once Again in the Housing Market
By Diana Olick, CNBCHomebuyers are increasingly opting to put less money down when purchasing their homes, increasing their risk should the housing market, and specifically home prices, falter yet again.
-
Making a Big Money Move? Why You Should Probably Consult a Financial Adviser
By Beth Pinsker, ReutersPeople hire financial advisers with the very obvious goal of getting advice on how to handle their money. So why do investors often cut advisers out of consequential decisions? Some advisers say...
-
Are Fidget Spinners Dangerous? Consumer Group Issues a Warning
The Consumer Product Safety Commission is warning that fidget spinners might not be suitable for everyone.
-
The Best City in America for Working Parents
While it’s tough for working parents across the country, there are some cities where the load is a bit lighter, thanks to lower childcare costs and shorter commute times.
-
Here’s How Much More Your Health Insurance Will Cost Next Year
Consumers who get health insurance through their jobs won’t see rate hikes in the double digits like those on the Obamacare exchanges, but they’ll still see the cost of health care go up.
-
Would Trump Take Away Your Mortgage Interest Deduction?
By Rob GarverIn the complicated world of federal tax expenditures, there is perhaps no provision more loved by its beneficiaries and more hated by academic economists than the mortgage interest deduction. For...
-
Allergan agrees to Actavis deal for $66 billion
By Reuters and Svea Herbst-BaylissThe offer values Allergan at $219 per share, compared with its Friday close of $198.65. Valeant's latest cash-and-stock offer is currently worth about $54 billion. (Reporting by Caroline Humer;...
-
Merck KGaA says Pfizer deal exclusive
By Ludwig Burger and Ben Hirschler, Reuters"This is an exclusive collaboration in the PD-1, PD-L1 space," said Belen Garijo, who will take over leadership of Merck's healthcare business from next year. She added that the two sides could...
-
Pfizer dampens Astra bid hopes by signing German Merck cancer deal
By Ludwig Burger and Ben Hirschler, ReutersFRANKFURT/LONDON (Reuters) - Pfizer punctured investor expectations of a renewed bid for AstraZeneca on Monday by signing a major cancer drug deal with Germany's Merck KGaA , reducing the U.S. firm's...
-
Fending Off the High Cost of a Fender Bender
‘Tis the season for fender benders. Roughly 13 percent of car accidents occur in parking lots, according to Nationwide Insurance , and during the holiday shopping season those lots can get crowded...
-
German Merck, Pfizer in cancer immunotherapy deal
By ReutersThe two companies will develop Merck's so-called anti-PD-L1 agent as a single therapy as well as in combinations with Pfizer's and Merck's portfolio of approved and experimental drug candidates...